Analysis of AstraZeneca's market potential, including China and IRA impacts, and the importance of key readouts in 2025 for ...

The drug and biotech industry had a tough time in the past couple of months after Trump announced the appointment of Robert F ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Olaparib is under clinical development by AstraZeneca and currently in Phase II for Malignant Mesothelioma. According to GlobalData, Phase II drugs for Malignant Mesothelioma have a 42% phase ...

INR:2526. what is handicap in betting football Pharmaceutical giants' Q3 performance comparison: AZ and Merck have the ...

AstraZeneca's Lynparza for pancreatic cancer receives support from FDA advisory committee Hainan Province announces the official im ...

INR:0260. rummy partner app AstraZeneca/Merck Lynparza (Lynparza) received 3 approvals in Japan New mechanism! Inflammatory bowel disease is expected to usher i ...

INR:1736. rivalry bet apk AstraZeneca/Merck Lynparza (Lynparza) received 3 approvals in Japan Propharma: Memantine Hydrochloride Tablets Obtained Drug Registratio ...

INR:1771. rummy kadak AstraZeneca/Merck Lynparza (Lynparza) received 3 approvals in Japan The weapon found by the Sichuan University research team to fight against su ...

INR:5211. online casino sa Routine operation or market overreaction? AstraZeneca's COVID-19 vaccine Phase III trial suspended First-line maintenance treatment fo ...

INR:3817. ipl match where to watch AstraZeneca's Forxiga for chronic heart failure and Lynparza approved in the EU "Pharmaceutical Speed ​​Reading Cl ...

AbbVie (NYSE: ABBV) recently announced new results from two ongoing clinical trials evaluating epcoritamab, a CD3xCD20 bispecific T-cell-engaging antibody administered subcutaneously, in adult ...